Skip to main content
OpenTrials
Completed

NCT Number: NCT05894278

A Prescription Audit of Inpatient Department of Super Speciality Hospital in National Capital Region of India

Prescription auditing is the art to check the detailing, compatibility and performance of the generated prescription from the physician to the pharmacist and patient, by means of the WHO checklist for prescription auditing. An audit is defined as the review and evaluation of the healthcare procedures and documentation to compare the quality of care provided, with accepted standards.

In this study, we will collect In-patient prescriptions from Fortis Hospital. And it will be evaluated for 13 list out parameters i.e Hospital unique ID, patient name, age, sex, weight, date of consultation, cleanliness and legibility, brief history, allergies, clinical examination, presumptive or definite diagnosis, medicine prescribed by generic name, dose, duration, history of a previous adverse event, appropriate abbreviations used, drug-drug interaction, drug duplication, doctor name, registration number and signature. The study is analyzed by Statistical Process Control (SPC).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Review of In-patient Prescription

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fortis Hospital

Noida, Uttar Pradesh, 201301, India

About this study

Aim of the study:

The aim of the study is to evaluate the quality of the prescription provided to the inpatient.

Objectives of the study:

To study the quality of good prescription In minimization of prescription errors and medication errors Also to comply with good clinical practice Enhancement of patient safety In the maintenance of rational prescribing To study the quality of care provided by the hospital to the patient

Plan of study:

To select the patient based on inclusion and exclusion criteria To collect the information from IP prescription and drug chart To identify prescribing errors and medication error To study the management of good prescription

Methodology:

Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)

Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)

Subject Eligibility:

  • Inclusion Criteria Participants who are willing to participate Participants who are admitted in the in-patient department Participants admitted during the study period Participants who have a prescription which is legible and complete
  • Exclusion Criteria Participants who are unwilling to provide the required information Participants who are not admitted the in-patient department Participants whose prescription is not legible and competent
  • Source of the data: Review of In-patient prescription

Sample Size:

300 prescriptions

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants who are willing to participate
  • Participants who are admitted in the in-patient department
  • Participants admitted during the study period
  • Participants who have a prescription which is legible and complete

Exclusion criteria

  • Participants who are unwilling to provide the required information
  • Participants who are not admitted the in-patient department
  • Participants whose prescription is not legible and competent

Treatment and study plan

Prescription data collection

Other

Prescription data collection

Primary outcomes

  1. Percentage prescription

    Time frame: March 2023 and May 2023

    Prescription filled for specific parameter

Sponsors and collaborators

Lead sponsor

Kakatiya University

Other

Collaborators

  • Fortis Hospital, India

Registry information

Official study title

A Prescription Audit of Inpatient Department of National Accreditation Board for Hospitals and Healthcare Providers Approved Super Speciality Hospital in National Capital Region of India

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jun 8, 2023
Registry last updated
Jun 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.